ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
This analytic paper presents the evidence on the potential of acetylsalicylic acid (ASA) for the mortality reduction in patients with cardiovascular disease. The focus is on the “minimal” effective dose of ASA, in terms of its effects on survival. The discussion of the ASA form and dose selection al...
Main Author: | O. V. Averkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2012-08-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1255 |
Similar Items
-
ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01) -
Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk
by: F. I. Belyalov, et al.
Published: (2016-09-01) -
Cinacalcet Treatment Significantly Improves All-Cause and Cardiovascular Survival in Dialysis Patients: Results from a Meta-Analysis
by: Yuan Zu, et al.
Published: (2019-11-01) -
ANTITHROMBOTIC ACTIVITY OF SBT-828 COMPOUND
by: V. S. Sirotenko, et al.
Published: (2015-09-01) -
Thigh Circumference and Risk of All-Cause, Cardiovascular and Cerebrovascular Mortality: A Cohort Study
by: Chen C, et al.
Published: (2020-10-01)